Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05734235 · ClinicalTrials.gov registry record · Phase 1
UVB-Induced MVP Release in Human Skin
A Phase 1 study, sponsored by Wright State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT05734235: Completed Phase 1 study, sponsored by Wright State University.
NCT05734235 is a Phase 1 study that has completed, run by Wright State University. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05734235, a Phase 1 study, has completed, sponsored by Wright State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study is designed to assess if ultraviolet B radiation (UVB) found in sunlight causes the release of microvesicle particles in human skin, and if antioxidant vitamins can block their production.
Primary Outcome
Levels of microvesicle particles will be determined from skin biopsies
Interventions
- DIETARY_SUPPLEMENT Vitamin C
- DIETARY_SUPPLEMENT Vitamin E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2022-10-26 |
| Phase | Phase 1 |
What the finished NCT05734235 record still lists
NCT05734235 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Vitamin C is the first listed.
NCT05734235 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05734235 about?
NCT05734235 is a clinical study titled "UVB-Induced MVP Release in Human Skin". This study is designed to assess if ultraviolet B radiation (UVB) found in sunlight causes the release of microvesicle particles in human skin, and if antioxidant vitamins can block their production.
What is the current status of trial NCT05734235?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2018-07-16. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT05734235?
The interventions under investigation include: Vitamin C (DIETARY_SUPPLEMENT), Vitamin E (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05734235?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05734235's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI